Medical cannabis is used to treat and cure diseases and their symptoms. It is also known by the name of Medical Marijuana. Particular strains like Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used for the treatment of certain health disorders, pain management, blood pressure, sensory stimulus and seizures.
The increasing legalization in the use and acceptability of medicinal cannabis in certain nations are continuously leading to the growth of the target market. The legalization of cannabis is anticipated to spur the expansion of the Medical Cannabis Market growth.
Key Growth Drivers and Opportunities
Increasing legalization of cannabis in medicines: Several developing nations have started legalizing the use of cannabis for the purpose of therapeutics and medicines, which in turn is leading to the growth of the target market. Numerous businesses and organizations are also taking measures to spread awareness as well as launching steps to fully legalize medicinal cannabis. As a result, there has been an upsurge in the growth of the Medical Cannabis Market.
In April 2023, the state government of Himachal Pradesh in India is contemplating to legalize cannabis cultivation. It has been reported that the members of panel will look out for certain factors like how will it be cultivated and who will be allowed to cultivate it, and for what all medical purposes will it be used.
Challenges
The market is limited by regulatory and legal barriers, limited clinical evidence and research restrictions, and supply chain and production challenges and among others. The availability of medicinal cannabis therapies through insurance are also sometimes restricted, which further hinders its uptake. As a result, this is a critical factor which becomes a barrier to the growth of the Medical Cannabis Market.
Innovation and Expansion
InterCure to Acquire ISHI, Unlocking Access to Premium US Cannabis Technology, Brands
In September 2025, InterCure Ltd. announced the strategic acquisition of Botanico Ltd., also known as ISHI, a premium medical cannabis technology and brand company that delivers immediate access to advanced cultivation technologies and established partnerships with leading American cannabis operators.
The acquisition comes as the U.S. cannabis market stands at a historic potential inflection point, with the Trump administration reportedly exploring the rescheduling of cannabis from Schedule I to Schedule III1—a transformative regulatory shift that could unlock unprecedented opportunities for international cannabis companies such as InterCure.
High Tide to Become Major Player in German Medical Cannabis Market through Acquisition of Majority Stake in Remexian Pharma GmbH
In August 2024, High Tide Inc., announced that it is entering the fast growing German medical cannabis market by signing a definitive agreement pursuant to which the Company will acquire 51% of Remexian Pharma GmbH, for a preliminary estimated purchase price of €27.2 million, subject to certain adjustments on closing (the “Transaction”), and will have an option to acquire the remaining interest in Remexian.
Incannex Healthcare acquires medicinal cannabis biotech APIRx
In August 2022, Medicinal cannabis company Incannex Healthcare Ltd has finalised its acquisition of APIRx Pharmaceuticals, an innovative biotechnology company focused on research, development and production of prescription pharmaceutical cannabinoid medicines. The deal sees 22 active clinical and pre-clinical research and development projects transferred to Incannex, underpinned by an intellectual property portfolio of 19 patents and 23 pending patents. Incannex has one of the world’s largest portfolio of patented medicinal cannabinoid drug formulations and psychedelic treatment protocols.
Inventive Sparks, Expanding Markets
The key players operating the medical cannabis market include, Trilay, BOL Pharma, Medreleaf Corporation, Canopy Growth Corporation, Aurora Cannabis, Inc., Aphria, Inc., Insys Therapeutics, Inc., GW Pharmaceuticals, Plc., MGC Pharmaceuticals, and Medical Cannabis Inc., and others
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
